SUMMARY1. The effect of the microtubule-disruptive agent, nocodazole (methyl [5-(2-thienylcarbonyl)-lH-benzimidazol-2-yl] carbamate), on the water permeability response to vasopressin or the synthetic cyclic AMP analogue, 8-parachlorophenylthio-cyclic AMP (8-CPT-cAMP), has been investigated in isolated cortical collecting tubules from rabbit kidneys, perfused in vitro.2. Pre-treatment with nocodazole, 1-4 ,ug ml-', had no significant effect on basal water permeability, but inhibited the increase in hydraulic conductivity elicited by vasopressin, 50 gU ml-', in a dose-dependent manner. Inhibition of the response to the hormone averaged 65+6 % (n = 8, P < 0-001) at a nocodazole concentration of 41,ag ml-'.3. Nocodazole, 1-4 jtg ml-', had no effect on the increase in lumen-negative potential difference (PD) induced by the hormone.4. Pre-treatment with nocodazole, 4 jug ml-', inhibited the development of the water permeability response to 8-CPT-cAMP, 1-8 x 10-5 M, by 45 + 7 % (n = 7, P < 0-001).5. When collecting tubules were exposed to nocodazole, 4,g ml-', after the hydrosmotic response to vasopressin had been fully established, the drug had no inhibitory effect on the maintenance of a high water permeability.6. The results are consistent with the view that cytoplasmic microtubules play a role in the initiation of the water permeability response to vasopressin in the mammalian cortical collecting tubule at a cellular site beyond the generation of cyclic AMP.